Reduced folate carrier transports thiamine monophosphate: an alternative route for thiamine delivery into mammalian cells. Am J Physiol Cell Physiol 282: C1512-C1517, 2002. First published February 13, 2002 10.1152/ajpcell.00547. 2001.-Although the reduced folate carrier RFC1 and the thiamine transporters THTR-1 and THTR-2 share ϳ40% of their identity in protein sequence, RFC1 does not transport thiamine and THTR-1 and THTR-2 do not transport folates. In the present study, we demonstrate that transport of thiamine monophosphate (TMP), an important thiamine metabolite present in plasma and cerebrospinal fluid, is mediated by RFC1 in L1210 murine leukemia cells. Transport of TMP was augmented by a factor of five in cells (R16) that overexpress RFC1 and was markedly inhibited by methotrexate, an RFC1 substrate, but not by thiamine. At a near-physiological concentration (50 nM), TMP influx mediated by RFC1 in wild-type L1210 cells was ϳ50% of thiamine influx mediated by thiamine transporter(s). Within 1 min, the majority of TMP transported into R16 cells was hydrolyzed to thiamine with a component metabolized to thiamine pyrophosphate, the active enzyme cofactor. These data suggest that RFC1 may be one of the alternative transport routes available for TMP in some tissues when THTR-1 is mutated in the autosomal recessive disorder thiamine-responsive megaloblastic anemia. SLC19A transporters; thiamine-responsive megaloblastic anemia; thiamine pyrophosphate; thiamine homeostasis; vitamin B1 uptake THIAMINE (VITAMIN B 1 ), in its coenzyme form thiamine pyrophosphate, plays a critical role in oxidative phosphorylation and in the pentose phosphate pathway. Dietary thiamine deficiency causes beriberi and Wernicke encephalopathy; the latter is often encountered in chronic alcoholism (17). Mutations in the thiamine transporter gene (THTR-1, SCL19A2) are the cause of an autosomal recessive disorder, thiamine-responsive megaloblastic anemia (TRMA), associated with diabetes mellitus and sensoneural deafness (5, 9, 14, 19, 25, 30) . This transporter is highly expressed in skeletal muscle and to a lesser extent in heart and placenta. Expression is very low in small intestine and kidney despite higher thiamine uptake in these tissues than muscle (27), suggesting that an alternative transport route(s) for thiamine is present in these organs. Recently, a gene (SLC19A3) homologous to SLC19A2 was identified (7), and its function was established as a second thiamine transporter, THTR-2 (23).
THIAMINE (VITAMIN B 1 ), in its coenzyme form thiamine pyrophosphate, plays a critical role in oxidative phosphorylation and in the pentose phosphate pathway. Dietary thiamine deficiency causes beriberi and Wernicke encephalopathy; the latter is often encountered in chronic alcoholism (17) . Mutations in the thiamine transporter gene (THTR-1, SCL19A2) are the cause of an autosomal recessive disorder, thiamine-responsive megaloblastic anemia (TRMA), associated with diabetes mellitus and sensoneural deafness (5, 9, 14, 19, 25, 30) . This transporter is highly expressed in skeletal muscle and to a lesser extent in heart and placenta. Expression is very low in small intestine and kidney despite higher thiamine uptake in these tissues than muscle (27) , suggesting that an alternative transport route(s) for thiamine is present in these organs. Recently, a gene (SLC19A3) homologous to SLC19A2 was identified (7) , and its function was established as a second thiamine transporter, THTR-2 (23) .
Thiamine is present in human tissues and fluids mainly in three forms: thiamine, thiamine monophosphate (TMP), and thiamine pyrophosphate (TPP). Thiamine is converted to TPP by thiamine pyrophosphokinase, and TPP is hydrolyzed by thiamine pyrophosphatase to TMP, which is further hydrolyzed to thiamine by thiamine monophosphatase (26) . No specific metabolic role is known for TMP. Whereas TPP exists intracellularly exclusively, thiamine and TMP are present both intracellularly and extracellularly. In plasma, TMP is present at levels ϳ80% that of thiamine, whereas TMP concentrations exceed that of thiamine by 65% in cerebrospinal fluid (34) . Blood thiamine level is normal in patients with TRMA, suggesting that the majority of intestinal thiamine transport is not dependent on THTR-1 (28) .
The reduced folate carrier RFC1 is a major transporter for physiological folate in plasma, 5-methyltetrahydrofolate, as well as in antifolates (22) . Inactivation of RFC1 in mice results in early embryonic lethality, but in animals brought to term by administration to dams of high levels of folic acid, death occurs rapidly due to failure of hematopoietic tissues (38) . RFC1, THTR-1, and THTR-2 are a family of carriers within the major facilitator superfamily (29) . RFC1 shares protein sequence identity of ϳ40% with both THTR-1 and THTR-2 but is functionally distinct from the thiamine transporters. RFC1 does not transport thiamine, and THTR-1 and THTR-2 do not transport folates (6, 37) . However, RFC1 transports TPP, the major thiamine intracellular metabolite, and recent studies from this laboratory (37) demonstrated that the level of RFC1 expressed in murine leukemia cells is inversely related to the extent of net TPP accumulation. Hence, low RFC1 expression augments TPP accumulation in these cells, whereas high expression suppresses it.
Because RFC1 is an anion exchanger and has been shown to transport TPP, the current studies were designed to assess whether TMP is also a substrate for RFC1 in murine leukemia cells. The data indicate that RFC1 mediates transport of TMP, which is then rapidly hydrolyzed to thiamine and subsequently phosphorylated to TPP in these cells. These results provide an additional facet of the complex role that RFC1 may play in thiamine homeostasis. (10) . Tritiated thiamine and TMP were used immediately after purity was confirmed by HPLC (37) .
MATERIALS AND METHODS

Chemicals
Cells lines and culture conditions. The MTX r A line was selected from murine leukemia L1210 cells with a loss of RFC1 function due to a point mutation in the carrier (2, 31) . R16 cells have high-level expression of RFC1 obtained by transfection of murine RFC1 cDNA into MTX r A (2, 39). Cells were grown in RPMI 1640 medium containing 5% bovine calf serum (HyClone), 2 mM glutamine, 20 M 2-mercaptoethanol, penicillin (100 U/ml), and streptomycin (100 g/ml) at 37°C in a humidified atmosphere of 5% CO 2. R16 cells were grown with G418 at a concentration of 750 g/ml to ensure stable, high-level expression of RFC1.
Transport studies. Cells were harvested, washed twice with HEPES-buffered saline (HBS; 20 mM HEPES, 140 mM NaCl, 5 mM KCl, 2 mM MgCl 2, and 5 mM glucose, pH 7.4), and resuspended in HBS to 2.0 ϫ 10 7 cells/ml. Cell suspensions were incubated at 37°C for 25 min, after which uptake was initiated by the addition of [ Samples were taken at the indicated times. Uptake was terminated by injection of 1 ml of the cell suspension into 10 ml of ice-cold HBS. Cells were collected by centrifugation, washed twice with ice-cold HBS, dried, and digested with 1 N NaOH in an 8-ml vial. After the liquid scintillation fluor was added, radioactivity was assessed in a liquid scintillation spectrometer. For influx experiments, the tritiated compound with or without unlabeled chemicals was added to the cell suspension to initiate uptake. Intracellular tritium was expressed in units of nanomoles per gram dry weight of cells. One milligram of dry cells corresponds to 6 ϫ 10 6 L1210 cells. Determination of rates of TMP hydrolysis. [ 3 H]TMP was exposed to 250 l of cell suspension or to the supernatant obtained by centrifugation of the cell suspension. Either the concentration of [ 3 H]TMP, the density of the cell suspension, or the interval of incubation was varied. TMP hydrolysis was stopped by the addition of 15 l of 100% trichloroacetic acid. After a brief centrifugation, the supernatant was extracted three times with water-saturated ethyl ether. Unlabeled thiamine, TMP, and TPP, each at a final concentration of 1 mM, were added to the mixture, and 20 l were loaded on a 20 ϫ 20-cm thin-layer chromatography plate with a 250-m layer of silica gel (Whatman). The plate was developed by a solvent mixture of diethanolamine-methanol-formic acid-67 mM dibasic sodium phosphate (1:15:1.5:5) for 2.5 h (20) . Under these conditions, TPP (R f ϭ 0.26), TMP (Rf ϭ 0.37), and thiamine (Rf ϭ 0.51) were well separated. The TMP and thiamine spots were traced under ultraviolet light, removed from plates, and added to scintillation vials. The silica gel was incubated in NaOH (2 N, 0.5 ml) for 15 min at room temperature, and tritium was measured on a liquid scintillation spectrometer after introduction of the fluor. When TMP hydrolysis was complete, radioactivity recovered as thiamine was equivalent to radioactivity recovered from TMP in the absence of TMP hydrolysis, indicating a 100% conversion of TMP to thiamine.
Measurement of intracellular thiamine metabolites. R16 cells were exposed to 1 M [ 3 H]TMP for 1 min after a 25-min incubation in HBS. Cells were washed twice with ice-cold HBS. Half of the cell pellet was processed for dry weight and total cell tritium, as described in Transport studies. The other half was resuspended in 250 l of HBS, and 15 l of 100% trichloroacetic acid were added. The digest was processed for thin-layer chromatography as described above to assess levels of thiamine, TMP, and TPP. Cell levels were expressed in units of picomoles per gram dry weight, according to the percentages of total tritium recovered.
RESULTS
Influx of TMP in murine leukemia cells.
Initial uptake of TMP was assessed in three murine leukemia cell lines with different levels of RFC1 expression: 1) L1210 wild-type cells; 2) MTX r A, a variant of L1210 cells that has lost RFC1 activity due to a point mutation (A130P) in the third transmembrane domain (2); and 3) R16 cells derived by transfection of murine RFC1 into MTX r A cells with carrier expression and activity nine times greater than that of L1210 cells (39) . As illustrated in Fig. 1 , influx of TMP in MTX r A cells was ϳ20% that of L1210 cells, whereas TMP influx in R16 was approximately fivefold higher than that of L1210 cells. Thus influx of TMP correlated with the level of RFC1 expression in these cell lines. The high ordinate intercept in R16 cells could be attributed in part to a rapid deviation from initial rates as simulated by the interrupted line.
Inhibitory effect of MTX and thiamine on Fig. 2 , 100 M MTX abolished ϳ90% of TMP influx in R16 cells over a 25-s interval of uptake, whereas 10 M thiamine had no inhibitory effect at all, indicating that virtually all TMP influx in R16 cells was mediated exclusively by RFC1 under these conditions. Because RFC1 is highly expressed in this cell line, the component of TMP influx mediated by this process is maximized. MTX also inhibited Ͼ50% of TMP influx in L1210 cells with lesser RFC1 expression but had no effect at all on TMP influx in MTX r A cells, which lack functional RFC1. In the presence of 10 M thiamine, however, TMP influx in L1210 and MTX r A cells was reduced by 20 and 37%, respectively. As indicated in Chemical instability of TMP in vitro, the emergence of a thiamine-inhibitable TMP influx component in these cells, with lower or absent RFC1 expression, was subsequently found to be due to the rapid hydrolysis of
Comparison of TMP and thiamine influx in L1210 cells at physiological substrate concentrations. Because TMP and thiamine are present in plasma and cerebrospinal fluid at a concentration range of 3-50 nM (34), the relative contribution of TMP and thiamine delivery to cells was assessed by measuring influx of these two substrates at 50 nM over 40 s. TMP influx was ϳ70% that of thiamine influx (Table 1 ). More than half of TMP influx was blocked by 100 M MTX, and half of the remaining activity was further inhibited by 10 M Fig. 3 . Dependence of TMP hydrolysis on incubation time, cell density, and substrate concentration. A: L1210 cells at a density of 2 ϫ 10 7 cells/ml were incubated in HBS for 25 min at 37°C. A portion of cell suspension was centrifuged to obtain cell-free supernatant. 3 H]TMP at a concentration of 50 nM with or without 100 M MTX, 10 M thiamine, or both were added to the cell suspension. Initial uptake rates were determined in the same way as described in Fig. 1 for L1210 cells (within 40 s) . Data are means Ϯ SD of 3 experiments performed on different days. thiamine. The latter is attributed to inhibition of influx of thiamine derived from the hydrolysis of TMP (see Chemical instability of TMP in vitro). Thiamine influx at 50 nM was decreased by ϳ75% in the presence of unlabeled thiamine. Thus, in L1210 cells, influx of TMP via RFC1 was approximately half the carrier-mediated influx of thiamine at a physiological substrate concentration.
Chemical instability of TMP in vitro. Chemical stability of TMP was assessed under the same conditions as in the influx experiments. Cells in HBS at a density of 2 ϫ 10 7 cells/ml were incubated in the transport buffer for 25 min, after which [ 3 H]TMP was added and the identity of extracellular radiolabel was assessed by thin-layer chromatography. As indicated in Fig. 3A , 80% of [ 3 H]TMP was hydrolyzed to thiamine by 1 min of incubation. By 3 min, no TMP could be detected. When supernatant was separated from the suspension after 25 min of incubation, after which [ 3 H]TMP was added, hydrolysis of TMP was also detected but at a reduced rate. There was no detectable degradation of TMP in HBS alone over a 5-min incubation. These findings suggest that TMP hydrolysis is mediated by phosphatases associated with the L1210 cell membrane and secreted into the suspension buffer.
The rate of TMP hydrolysis was determined both as a function of cell density and substrate concentration. After a 2-min incubation with 10 5 cells/ml, 90% of TMP was unchanged. However, as the cell density was increased, the rate of hydrolysis was also markedly increased (Fig.  3B) . The extent of TMP hydrolysis was also dependent on the concentration of substrate (Fig. 3C) . The percentage of TMP hydrolysis was constant at ϳ70% over a concentration range of from 10 nM to 1 M but decreased to 10% as the TMP concentration increased from 1 to 100 M, suggesting saturation of the phosphatase(s).
Affinity of RFC1 for TMP. In measuring the affinity of RFC1 for TMP, R16 cells were used to maximize the component of influx attributable to TMP uptake via RFC1 because this carrier is highly expressed in this cell line. Also, MTX influx can be measured over a very short interval, minimizing hydrolysis of TMP. As shown in Fig. 4 Most of the thiamine transported into L1210 cells is converted to TPP, the active cofactor for several enzymes (37) . As indicated in Fig. 5 , about half of TMP transported into R16 cells was converted to thiamine within 1 min; 15% was identified as TPP and 35% remained as TMP. MTX, at a concentration of 100 M, suppressed intracellular levels of thiamine, TMP, and TPP; the greatest suppression was observed for thiamine. In 6 . A model for transcellular flux and intracellular metabolism of thiamine, TMP, and TPP in nonpolarized cells. Thiamine (T) uptake and efflux are mediated by the facilitative thiamine transporters THTR-1 and THTR-2, whereas influx and efflux of TMP are mediated by RFC1. Because TPP is not present extracellularly, RFC1-mediated TPP transport is unidirectional out of cells. TPP is synthesized from thiamine by thiamine pyrophosphokinase (TPK). TPP is hydrolyzed by thiamine pyrophosphatase (TPPase) to TMP, which is further hydrolyzed to thiamine by thiamine monophosphatase (TMPase). TPP is also hydrolyzed to thiamine by other phosphatases (26).
contrast, 10 M thiamine had no effect on total cell tritium, with only negligible effects on cell levels of tritiated TMP or TPP. These observations indicate that [ 3 H]thiamine appearing in cells exposed to [ 3 H]TMP was due to TMP hydrolysis to thiamine within cells and not to influx of thiamine from the extracellular compartment. These data also demonstrate that transport of TMP via RFC1 results in the delivery of a precursor of the active thiamine cofactor TPP into cells.
DISCUSSION
Recent studies from this laboratory demonstrated that TPP is a good substrate for RFC1 and that its transport into cells correlates with the level of RFC1 expression (37) . Because TPP is present exclusively in the intracellular compartment where it is formed by thiamine pyrophosphokinase, RFC1 action with respect to this substrate is asymmetrical. This asymmetry results in the unidirectional export of TPP, depression of the intracellular TPP level, and the hydrolysis of TPP to thiamine in the extracellular space. On the basis of this consideration, cells that express high levels of RFC1 would be at a disadvantage under conditions of thiamine deficiency.
We now demonstrate that RFC1 also transports TMP, a normal constituent of plasma and cerebrospinal fluid, present at concentrations nearly equivalent to thiamine. Once transported into cells, TMP is converted to thiamine by thiamine monophosphatase, followed by phosphorylation of thiamine to TPP by thiamine pyrophosphokinase (Fig. 6) . Hence, the level of RFC1 expression will determine the rate of delivery of this thiamine precursor into cells. Under conditions of thiamine deficiency, when blood levels of thiamine and TMP are low, this added transport via RFC1 might not be important. However, when the thiamine carrier THTR-1 is not functional as occurs in TRMA (33), RFC1 could be an important alternative route for thiamine uptake into cells, along with other potential transport pathways for thiamine such as THTR-2 (23) (Fig. 6) . Indeed, the pattern of RFC1 tissue expression may be one of the determinants of the selective organ and metabolic defects associated with TRMA-macrocytic anemia, sensoneural deafness, and diabetes mellitus. It is interesting in this regard that dietary thiamine deficiency leads to cardiac (beriberi) and brain (Wernicke's syndrome) abnormalities, whereas TRMA leads to functional defects in only a limited number of other tissues.
The high level of expression of RFC1 in the apical brush border of the choroid plexus suggests that this may be an important route of TMP transport, because TMP is present at higher levels than is thiamine in cerebrospinal fluid (35) . High expression of RFC1 in the brush border of small intestinal cells could be a route for absorption of TMP and TPP present in the gut (35) . However, because of the high phosphatase level in intestinal brush border, these phosphorylated compounds are probably hydrolyzed to thiamine before they are absorbed. Our results suggest that at least part of TMP transport across rat everted jejunal sacs reported previously could be mediated by RFC1 (11) . However, RFC1 expressed in intestine has a low pH optimum (4, 18, 24) , and the extent to which TMP could be transported by this mechanism under these conditions remains unclear. On the other hand, the transport activity of THTR-1 and THTR-2 is optimal at high pH (6) , so that the extent to which thiamine is transported via this carrier is also uncertain at the pH present in the microenvironment of intestinal villi (21) .
Unlike THTR-1, RFC1 is an anion exchanger. Folates are bivalent anions with negative charges at the two carboxyl groups of the glutamate moiety. RFC1 is inhibited by a variety of inorganic and organic anions, including the organic phosphates such as the adenine nucleotides (12, 16, 36) . It is the asymmetrical distribution of organic phosphates across cell membranes, with their high intracellular electrochemical potential, that is thought to be the energy source for the uphill transport of folates into many mammalian cells (12, 16, 36) . Because TPP and TMP have comparable affinities for RFC1 but differ in total charge, the data suggest that the thiamine moiety may play an important role in binding to the carrier. On the other hand, thiamine itself is not transported by RFC1 at all, likely due to thiamine's positive charge, which is reversed by phosphorylation. Further evidence for the role of this moiety in binding to RFC1 comes from the observation that other organic anions, such as ADP and AMP, that share the same charge have a much lower affinity for RFC1 (15) . It remains to be determined whether there are critical charged residues in RFC1 vs. THTR-1 and THTR-2 that determine the charge specificity of these carriers for folates and thiamine as has been demonstrated for the rat organic anion transporter rOAT3 (8) .
These studies demonstrate the high degree of chemical instability of TMP in cell suspensions. Hence, it is unclear why this substance is present at levels comparable to thiamine in plasma. It is possible that TMP is bound to circulating proteins that protect it from degradation and/or that this component is restored by the slow but constant exit of TMP and/or TPP from cells with subsequent hydrolysis by thiamine pyrophosphatase (Fig. 6 ). These findings indicate that previous suggestions that thiamine and TMP share the same transport route, based on TMP competition with radiolabeled thiamine for transport, are erroneous (1, 3, 13, 32) . It is highly likely that apparent inhibitory effects are due to rapid hydrolysis of TMP to thiamine that, in turn, inhibits radiotracer thiamine uptake into cells. It is clear that any studies focused on the transport of TMP or TPP must be designed to minimize, and correct for, the rapid degradation of these compounds to thiamine. This work was supported by National Cancer Institute Grant CA-82621.
